Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Anoop Misra and Awadhesh Singh.
Anoop Misra
Connection Strength
10.025
Awadhesh Singh
  1. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021 Jul-Aug; 15(4):102146.
    View in: PubMed
    Score: 0.946
  2. Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature. Diabetes Metab Syndr. 2021 Jan-Feb; 15(1):159-167.
    View in: PubMed
    Score: 0.919
  3. Impact of COVID-19 and comorbidities on health and economics: Focus on developing countries and India. Diabetes Metab Syndr. 2020 Nov-Dec; 14(6):1625-1630.
    View in: PubMed
    Score: 0.900
  4. Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician's perspective. Diabetes Metab Syndr. 2020 Sep - Oct; 14(5):971-978.
    View in: PubMed
    Score: 0.889
  5. Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.). Diabetes Metab Syndr. 2020 Sep - Oct; 14(5):729.
    View in: PubMed
    Score: 0.883
  6. "Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis." Diabetes Metab Syndr. 2020 Jul - Aug; 14(4):589-596.
    View in: PubMed
    Score: 0.882
  7. Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies. Diabetes Metab Syndr. 2020 Jul - Aug; 14(4):641-648.
    View in: PubMed
    Score: 0.882
  8. Editorial: Herd mentality, herds of migrants/people, and COVID-19 in India. Diabetes Metab Syndr. 2020 Jul - Aug; 14(4):497.
    View in: PubMed
    Score: 0.880
  9. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Diabetes Metab Syndr. 2020 Jul - Aug; 14(4):283-287.
    View in: PubMed
    Score: 0.876
  10. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020 Jul - Aug; 14(4):303-310.
    View in: PubMed
    Score: 0.876
  11. Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries. Diabetes Metab Syndr. 2020 May - Jun; 14(3):241-246.
    View in: PubMed
    Score: 0.874
  12. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr. 2020 May - Jun; 14(3):211-212.
    View in: PubMed
    Score: 0.218
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.